TB-500

What is TB-500?

TB-500 is a synthetic peptide based on the active region of Thymosin Beta-4 (Tβ4), a protein found naturally throughout the body that plays a central role in cell movement, tissue building, and repair. TB-500 reproduces the short, actin-binding fragment of that parent protein thought to be responsible for much of its regenerative activity.

In research and clinical settings, TB-500 is studied as a body-wide recovery agent. Like BPC-157, it has no direct hormonal or androgenic activity — it acts on the cellular machinery of healing rather than on the endocrine system. It is not an FDA-approved drug; in the United States it is prescribed only as a pharmacy-compounded preparation under physician supervision.

How TB-500 works

TB-500's defining action is the regulation of actin, the protein that forms the internal scaffolding of cells. By binding actin, it promotes the assembly and migration of the cells needed to rebuild injured tissue — allowing them to travel to a wound site, organize, and lay down new structure more efficiently.

Preclinical work also credits TB-500 with promoting angiogenesis (the growth of new blood vessels), reducing inflammation, and supporting the remodeling of collagen and extracellular matrix. These complementary effects on cell migration, blood supply, and tissue architecture are why it is studied for injuries to slow-healing structures such as tendon, ligament, and muscle.

What TB-500 is used for

What the evidence shows

Most of the TB-500 evidence base comes from animal and cell models, where Thymosin Beta-4 and its fragment have consistently accelerated healing — improving wound closure, tendon and muscle repair, and cardiac tissue recovery after injury [1][2].

Mechanistic studies attribute these effects to actin regulation, enhanced cell migration, and angiogenesis at the site of damage [2][3]. What is missing is high-quality human data: there are no large, published randomized controlled trials of TB-500 in people, so it sits in the category of a promising compound with strong preclinical support and limited clinical validation.

We present this honestly to every patient. TB-500 is used in clinical practice on the strength of its mechanistic rationale and safety profile, not on the basis of definitive human efficacy trials — and that distinction matters when you are deciding whether it fits your goals.

Dosing & administration context

TB-500 is most often administered by subcutaneous injection, sometimes near the area of injury. Protocols in clinical use commonly follow a loading phase over several weeks followed by less frequent maintenance dosing, with the amount expressed in milligrams per administration.

The specific dose, route, frequency, and duration are individualized by the prescribing physician based on the injury, your body weight, and your response — which is why we frame this as clinical context, not a self-dosing guide. TB-500 obtained without a prescription (research-only vials, gray-market powders) carries no guarantee of identity, purity, or sterility.

TB-500 is not an FDA-approved medication. Content on this page is clinical context for physician-supervised, pharmacy-compounded use — not a dosing guide or a substitute for medical advice.

Safety & side effects

Across preclinical studies TB-500 has shown a wide safety margin, with no consistent pattern of serious toxicity even at high doses. Reported effects in clinical use are generally mild and self-limiting.

Because human safety data are limited, we screen carefully before prescribing and monitor throughout a course. The most important safety principle is source control — a pharmacy-compounded product from a licensed 503A/503B pharmacy is a fundamentally different risk profile than a research vial of unknown origin.

How Strong Health prescribes TB-500

At Strong Health, TB-500 is prescribed only after an in-person or telehealth physician evaluation, a review of your injury history, and — where relevant — labs. It is dispensed exclusively through licensed 503A or 503B compounding pharmacies under physician orders; we do not sell or recommend research-only product.

We treat TB-500 as one component of a recovery plan, not a standalone fix. For tendon and ligament injuries it is frequently combined with BPC-157 and paired with appropriate rehabilitation, since their proposed mechanisms are complementary. Your physician sets the protocol, reviews your response at scheduled intervals, and adjusts or stops treatment based on how you actually heal.

Available in person at our Miami (Brickell) clinic and via telehealth across our service areas.

Frequently asked questions